Zydpla1
ZYDPLA1 is a novel, orally-administered small molecule DPP-4 inhibitor designed for type 2 diabetes research. It is utilized in both in vitro enzymatic assays and in vivo animal studies to investigate mechanisms of glycemic control and incretin hormone activity.
Product Specifications
CAS Number
1263402-76-1
Smiles
O (C1=CC (C (NC2=NC=CS2) =O) =CC (OC3=CC=C (C=C3) C4=NN=C (C) O4) =C1) [C@@H]5C (=O) N (C) CC5
Molecular Formula
C24H21N5O5S
Molecular Weight
491.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2985913-01 20 µg
Recombinant Human Seizure protein 6 homolog (SEZ6), partial
Sign In for Pricing
View Details orb2985913-02 100 µg
Recombinant Human Seizure protein 6 homolog (SEZ6), partial
Sign In for Pricing
View Details orb2985913-03 1 mg
Recombinant Human Seizure protein 6 homolog (SEZ6), partial
Sign In for Pricing
View Details